Navigation Links
Isis Reports Financial Results and Highlights for Third Quarter of 2008
Date:11/10/2008

Statements of Operations

(In Thousands)

Three months ended, Nine months ended,

September 30, September 30,

2008 2007 2008 2007

(unaudited) (unaudited)

Revenue:

Commercial revenue (1) $624 $1,049 $2,917 $2,490

Research and development revenue

under collaborative agreements 2,128 3,589 6,072 5,615

Total revenue 2,752 4,638 8,989 8,105

Expenses:

Cost of commercial revenue (2) 203 767 1,751 2,004

Research and development 6,313 3,791 16,788 10,002

Selling, general and

administrative 1,666 1,328 5,193 3,351

Total operating expenses 8,182 5,886 23,732 15,357

Loss from operations $(5,430) $(1,248) $(14,743) $(7,252)

(1) Ibis' commercial revenue has been classified as research and

development revenue under collaborative agreements on Isis' condensed

consolidated statement of operations.

(2) Ibis' cost of commercial revenue has been classified as research and

development expenses on Isis' condensed consolidated statement of

operations.

Regulus Therapeutics LLC

Statements of Operations

(In Thousands)

Three months ended, Nine months ended,

September 30, September 30,

2008 2007 2008 2007

(unaudited) (unaudited)<
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. OncoGenex Reports Third Quarter Financial Results
2. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
3. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
4. Dendreon Reports Third Quarter 2008 Financial Results
5. Osteotech Reports 2008 Third Quarter Financial Results
6. Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
7. Oncothyreon reports third quarter 2008 financial results
8. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
9. NeurogesX Reports Third Quarter 2008 Results
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
11. Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... BURLINGAME, Calif. , July 24, 2014  ECC ... Denver, Colorado with University College Hospital ... of a development project to finance, design, construct, and ... Ibadan, Nigeria . Under the first ... and prepare scoping documents and funding applications. UCH Ibadan ...
(Date:7/24/2014)... team led by group leader Yung-Eun Sung has ... synthesize sulfur-doped and nitrogen-doped graphenes which can be ... and fuel cells. Yung-Eun Sung is both a ... at Institute for Basic Science* (IBS) and a ... achievement has great significance with regards to the ...
(Date:7/24/2014)... at the University of Delaware, is known worldwide ... engineering, environmental sustainability and electronics. , His early ... a well-defined, crystalline structure. At the atomic scale, ... zeolites can separate molecules with size differences of ... a nanometer), making them useful to the chemical ...
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Cell Culture Market 2014-2018" report ... Cell culture is the in vitro ... such as research, cell studies, and biopharmaceutical production. Cell ... vaccine production. Cell culture instruments and cell culture consumables ...
Breaking Biology Technology:ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2University of Delaware researcher describes new approach for creating organic zeolites 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2
... N.Y., Dec. 9, 2011 BioSpecifics Technologies Corp. (NASDAQ: ... in class collagenase-based products marketed as XIAFLEX ® ... and Eurasia, today announced the appointment of  George Gould, ... 2011.  Mr. Gould, an attorney, is Principal of George ...
... RESEARCH TRIANGLE PARK, N.C., Dec. 9, 2011  CeNeRx ... commercializing innovative treatments for diseases of the central ... $4.85 million financing.  Existing investors Perseus Soros Biopharmaceutical ... Funds all participated in the financing.  CeNeRx plans ...
... LA CROSSE, Wis., Dec. 8, 2011  Prem Rabindranauth, MD, a ... in La Crosse, Wis., is using an ... to perform heart bypass surgery. To perform MICS, a very ... long cut through the breast bone that is needed with ...
Cached Biology Technology:BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors 2BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors 3BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors 4CeNeRx BioPharma Completes $4.85 Million Financing 2CeNeRx BioPharma Completes $4.85 Million Financing 3Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery 2
(Date:7/27/2014)... single computer cannot always find the solution a user ... cluster of computers that analyze a massive data set ... history to present you with targeted ads, and how ... movie. But big data is about more than just ... are generating unprecedented quantities of information. That data may ...
(Date:7/25/2014)... The burn scars on this false-color image from the Terra ... this year,s rash of wildfires in Eastern Russia. The ... the green background. The wildfires have broken across the ... Even in this false-color image from the MODIS instrument, ... the fires that continue. Two recent image features noted below ...
(Date:7/25/2014)... Nearly 600 scientists from 25 countries and ... Meeting organized by the Genetics Society of America ... in Seattle. The conference will feature close to ... results on topics including gene expression and regulation, ... technologies, evolution, aging, and a variety of diseases. ...
Breaking Biology News(10 mins):New tools help neuroscientists analyze 'big data' 2New tools help neuroscientists analyze 'big data' 3New tools help neuroscientists analyze 'big data' 4New tools help neuroscientists analyze 'big data' 5Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2
... delay the onset of Alzheimer,s disease, but none are able ... detection the key to Alzheimers patients maintaining a good quality ... a new device developed by the Georgia Institute of Technology ... inexpensive test that could be administered as part of a ...
... experiments was to test a computer algorithms ability to ... and classify them according to different contexts and individual ... 14 Hungarian sheepdogs (Mudi breed) in six different situations: ... were recorded with a tape recorder before being transferred ...
... plant material and burn it. If managed well most of ... by the growing plants, and so have a low impact ... the growing plants could be used to help solve other ... from the Department of Energy and Environment at Chalmers University ...
Cached Biology News:Portable device quickly detects early Alzheimer's 2Portable device quickly detects early Alzheimer's 3Biomass production -- careful planning can bring many benefits 2
... number is a new product number, ... number. If showing no availability yet, ... number (Z71,487-9) or contact customer service ... neck 100 mm, No. of sidearm ...
... a metabolically stable analog of ... uterine stimulant and abortifacient which ... induce labor. It induces luteolysis ... when given as an intramuscular ...
TGase3 (S-20)...
Amodiaquine...
Biology Products: